I very much agree that unprofessional submissions would be counterproductive. My personal view is that one or two very high quality submissions from HC people might be useful. However, I think large numbers that add nothing could have a quite negative effect.
I think anyone considering lodging a submission should seriously consider some questions first:
* Can you add anything useful, or will any important decision makers feel like they have wasted their valuable time by reading your submission?
* What about you means your view is relevant to AdComm/FDA decision processes? Eg. Have you or a loved one suffered from GVHD? Are you a doctor who treats GVHD? Are you part of a patient advocacy group? Are you a research scientist or a stem cell expert? Are you an American resident or citizen (AdComm/FDA are answerable to the American public, not random Aussies)?
I very much agree that unprofessional submissions would be...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |